Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hu

Showing results (871-880 of 921) with videos related to

Pageof 93
Sort By:
Zhonghua Yi Xue Za Zhi|January 17, 2017
[Risk factors for acute rejection in living-donor kidney transplant recipients in China: a subgroup analysis of a multi-center, registry study]X P Hu, Y Tian, T Y Zhu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|February 14, 2022
[Clinical application of serum Golgi protein 73 in patients with chronic liver diseases]Y N Liu, M J Yao, S J Zheng, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 20, 2023
[Response characteristics of tislelizumab combined with chemotherapy in first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer]S Lu, X M Yu, Y P Hu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2016
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trialsJ C-H Yang, L V Sequist, C Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2013
Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)G Chen, J Feng, C Zhou, et al.
Nature Genetics|September 29, 2022
The NALCN channel regulates metastasis and nonmalignant cell disseminationEric P Rahrmann, David Shorthouse, Amir Jassim, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|December 8, 2022
[Endovascular abdominal aortic aneurysm repair with a new stent graft:early results from a multicenter study]H P Zhang, X W Zhang, X C Dai, et al.
Genome Research|May 31, 2001
Analysis of the cat eye syndrome critical region in humans and the region of conserved synteny in mice: a search for candidate genes at or near the human chromosome 22 pericentromereT K Footz, P Brinkman-Mills, G S Banting, et al.
British Journal of Cancer|July 23, 2014
The impact of plasma Epstein-Barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational studyL-Q Tang, Q-Y Chen, S-S Guo, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 11, 2024
[Efficacy evaluation of extending or switching to tenofovir amibufenamide in patients with chronic hepatitis B: a phase Ⅲ randomized controlled study]Z H Liu, Q L Jin, Y X Zhang, et al.
Pageof 93

Showing results (871-880 of 921) with videos related to

Sort By:
Pageof 93
Zhonghua Yi Xue Za Zhi|January 17, 2017
[Risk factors for acute rejection in living-donor kidney transplant recipients in China: a subgroup analysis of a multi-center, registry study]X P Hu, Y Tian, T Y Zhu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|February 14, 2022
[Clinical application of serum Golgi protein 73 in patients with chronic liver diseases]Y N Liu, M J Yao, S J Zheng, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 20, 2023
[Response characteristics of tislelizumab combined with chemotherapy in first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer]S Lu, X M Yu, Y P Hu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2016
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trialsJ C-H Yang, L V Sequist, C Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2013
Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)G Chen, J Feng, C Zhou, et al.
Nature Genetics|September 29, 2022
The NALCN channel regulates metastasis and nonmalignant cell disseminationEric P Rahrmann, David Shorthouse, Amir Jassim, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|December 8, 2022
[Endovascular abdominal aortic aneurysm repair with a new stent graft:early results from a multicenter study]H P Zhang, X W Zhang, X C Dai, et al.
Genome Research|May 31, 2001
Analysis of the cat eye syndrome critical region in humans and the region of conserved synteny in mice: a search for candidate genes at or near the human chromosome 22 pericentromereT K Footz, P Brinkman-Mills, G S Banting, et al.
British Journal of Cancer|July 23, 2014
The impact of plasma Epstein-Barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational studyL-Q Tang, Q-Y Chen, S-S Guo, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 11, 2024
[Efficacy evaluation of extending or switching to tenofovir amibufenamide in patients with chronic hepatitis B: a phase Ⅲ randomized controlled study]Z H Liu, Q L Jin, Y X Zhang, et al.
Pageof 93